UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020173
Receipt number R000023212
Scientific Title Effects of catechin-penetration masks on influenza infection prevention: A pilot study
Date of disclosure of the study information 2015/12/14
Last modified on 2015/12/18 09:09:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of catechin-penetration masks on influenza infection prevention: A pilot study

Acronym

Effects of catechin-penetration masks on influenza infection prevention

Scientific Title

Effects of catechin-penetration masks on influenza infection prevention: A pilot study

Scientific Title:Acronym

Effects of catechin-penetration masks on influenza infection prevention

Region

Japan


Condition

Condition

Influenza

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of catechin-penetration masks on influenza infection

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Incidence rate of influenza infection

Key secondary outcomes

1) Days before influenza infection
2) Incidence rate of upper respiratory tract infections
3) Mask-wearing rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

Catechin mask / 60 days

Interventions/Control_2

Non-catechin mask / 60 days

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Written informed consent obtained before participation
2) Aged 20 years old or older
3) Opportunity to interact with influenza infected subjects
4) Willing and able to wear masks during the study period
5) Willing and able to fill out queationnaires

Key exclusion criteria

1) Green tea allergy
2) Allergy to mask material
3) Severe immune disease
4) Chronic systemic infectious disease
5) History of influenza infection within the previous 6 months and influenza infection within 24 h after participation
6) Subjects diagnosed by a physician inappropriate to participate in the study

Target sample size

250


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Yamada

Organization

University of Shizuoka

Division name

School of Pharmaceutical Sciences

Zip code


Address

52-1 Yada, Suruga-ku, Shizuoka, Japan

TEL

+81-54-264-5762

Email

hyamada@u-shizuoka-ken.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Yamada

Organization

University of Shizuoka

Division name

School of Pharmaceutical Sciences

Zip code


Address

52-1 Yada, Suruga-ku, Shizuoka, Japan

TEL

+81-54-264-5762

Homepage URL

http://u-shizuoka-ken.ac.jp

Email

hyamada@u-shizuoka-ken.ac.jp


Sponsor or person

Institute

University of Shizuoka

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

White Cross Nursing Home
Osaka University

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

静岡県立大学(静岡県)/ University of Shizuoka (Shizuoka)


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2014 Year 08 Month 26 Day

Date of IRB


Anticipated trial start date

2015 Year 12 Month 15 Day

Last follow-up date

2016 Year 03 Month 31 Day

Date of closure to data entry

2016 Year 07 Month 30 Day

Date trial data considered complete

2016 Year 08 Month 30 Day

Date analysis concluded

2016 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 12 Month 11 Day

Last modified on

2015 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023212


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name